Client Medical Alert: Testosterone

by admin on February 18, 2014 in Cases, Mass Tort, News

Our firm is issuing a Client Medical Alert on the use, in any form, of Testosterone or Low T. The FDA issued a safety announcement on January 31, 2014 stating that they were evaluating the risk of heart attacks, stroke, and death for people that were currently or had been on a testosterone product.

This safety announcement came after two studies, administered in January 2014 and November 2013, showed more than a 30% greater risk of having serious or deadly heart issues.  Other side effects linked include blood clots and pulmonary embolism.  Our firm are investigating these claims on behalf of clients against the manufacturers.  If you or a family member had a heart attack while on testosterone or after taking it, contact our office by calling 479-621-0006 or 1-800-698-3644.  You can also contact Sean Keith directly by sending an email to skeith@arkattorneys.com. Read more on http://www.dangerous-medicines.com.

What is Low T and Who Takes it?

Low T is simply a shortened name for low testosterone. The FDA has approved the use of testosterone only in conjunction with an associated medical condition. However, since 2006 the prescription for testosterone, which is being marketed under names such as Androderm, Androgel, Axiron, Fortesta and Testim and comes in gel form, shots and roll ons, has more than doubled. There have been a reported 5.3 million prescriptions since 2011.There are a wide variety of people who take testosterone and a large marketing campaign by Abbot and Eli Lilly, two of the largest manufacturers, have caused the interest in its usage to sky rocket. Testosterone in many forms is being taken by men of all ages because of the advertised benefits including more muscle mass, greater energy, sleep apnea, depression and greater libido.

What Do Studies Show?

Because of the increasing and widespread use for men of all ages, the studies on testosterone have been growing. A study of veterans with mean age of 60 was published in the November 2013 JAMA (Journal of American Medical Association). This study suggested a 30% increased risk of stroke, heart attack and death in the group that had been prescribed TT (testosterone therapy).A second study published in the January 2014 Journal of Clinical Endocrinology & Metabolism revealed that younger men who had a pre existing heart disease had a greater risk and that the risk of non fatal heart attacks was 36% higher for men 65 years and older. The greatest risk was seen in the 90 days after a prescription was filled.

CONTACT

Main:
224 S. 2nd St. Rogers, AR 72756

Ball Plaza:
112 W. Center Street, #555 Fayetteville, AR 72701

STAY IN TOUCH

Subscribe to our mailing list

* indicates required

CONTACT US

Main:
224 S. 2nd St. Rogers, AR 72756


Ball Plaza:
112 W. Center Street, #555 Fayetteville, AR 72701
ft